Waters Corporation WAT
NYSE · Healthcare · Medical - Diagnostics & Research
$440.45
Close on Fri, 20 Nov 2026 · market value $43.3B
What the price is betting on
Priced for a lot to go rightAt $440, the price assumes revenue grows about 67% a year for three years, from $5.6B to about $18.4B by FY2028. That is about five times what analysts expect and about three times the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 9.5% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than WAT? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$61
Base
$72
Bull
$120
Today $440
- Bear $61. The business grows 8% a year on average for only 1 year, then slows down.
- Base $72. The business grows 13% a year on average over the 3 years analysts forecast, shaped like their forecast, then slows over 10 years, starting from 7%.
- Bull $120. The business grows 18% a year on average for 5 years, longer than analysts forecast, then slows down.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$6.5B$6.5B, on the path
- FY2027$11.6B$7.2B, below the path
- FY2028$18.4B$7.6B, below the path
Each year's revenue at 67% growth from $5.6B in the 12 months to October 2026.
At a glance
Healthcare · Medical - Diagnostics & Research · listed on NYSE
- Revenue, FY2025
- $3.2B
- Growth, 3 years a year
- 26%
- Cash margin
- 17%
- Net debt
- $903M
- Shares, 3-year change
- −1%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.